JRI (Nuveen Real Assetome and Growth Fund) Stock Based Compensation: $0.00 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

JRI Nuveen Real Asset Income and Growth Fund JRI
50 GF Score
Price $12.94
GF Value $23.36
Valuation Significantly Undervalued
! 6 Warning Signs
View Full Analysis

What is Nuveen Real Assetome and Growth Fund Stock Based Compensation?

Nuveen Real Assetome and Growth Fund JRI -0.46% 50 Stock Based Compensation is $0.00 Mil as of Dec. 2025. GuruFocus rates JRI with a GF Score™ of 50/100 and a GF Value™ of $23.36 (Significantly Undervalued). The stock has 6 warning signs investors should review.

Nuveen Real Assetome and Growth Fund's Stock Based Compensation for the six months ended in Dec. 2025 was $0.00 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2025 was $0.00 Mil.

Nuveen Real Assetome and Growth Fund Stock Based Compensation Related Terms

Nuveen Real Assetome and Growth Fund Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Nuveen Real Assetome and Growth Fund's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nuveen Real Assetome and Growth Fund Stock Based Compensation Chart

Nuveen Real Assetome and Growth Fund Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

Nuveen Real Assetome and Growth Fund Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
JRI
50GF Score
Nuveen Real Asset Income and Growth Fund JRI
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nuveen Real Assetome and Growth Fund Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

What does a Stock Based Compensation of $0.00 Mil mean?
Nuveen Real Assetome and Growth Fund (JRI) has a Stock Based Compensation of $0.00 Mil as of Dec. 2025. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Nuveen Real Assetome and Growth Fund and its competitors.
Is Nuveen Real Assetome and Growth Fund's Stock Based Compensation too high?
Nuveen Real Assetome and Growth Fund's current Stock Based Compensation is $0.00 Mil. Overall, Nuveen Real Assetome and Growth Fund has a GF Score™ of 50/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nuveen Real Assetome and Growth Fund's Stock Based Compensation compare to HIX and MIY?
Nuveen Real Assetome and Growth Fund's Stock Based Compensation of $0.00 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for an Asset Management company?
A good Stock Based Compensation depends on the Asset Management industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Nuveen Real Assetome and Growth Fund and its competitors. Nuveen Real Assetome and Growth Fund's current Stock Based Compensation is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nuveen Real Assetome and Growth Fund stock overvalued right now?
Based on GuruFocus' analysis, Nuveen Real Assetome and Growth Fund (JRI) is currently considered Significantly Undervalued. The stock's GF Value™ is $23.36, compared to a current price of $12.94 — trading 44.6% below its estimated fair value. The current Stock Based Compensation is $0.00 Mil. Nuveen Real Assetome and Growth Fund's overall GF Score™ is 50/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Nuveen Real Assetome and Growth Fund (JRI), the current Stock Based Compensation is $0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nuveen Real Assetome and Growth Fund (JRI) Overvalued in 2026?

Based on GuruFocus' analysis, Nuveen Real Assetome and Growth Fund stock appears to be undervalued. The current stock price of $12.94 is trading 44.6% below its estimated GF Value™ of $23.36. GuruFocus considers Nuveen Real Assetome and Growth Fund to be Significantly Undervalued.

Key valuation signals for JRI:

  • Stock Based Compensation: $0.00 Mil
  • GF Value™: $23.36 vs. price of $12.94 (44.6% below fair value)
  • GF Score™: 50/100 with 6 warning signs

No single metric tells the full story. See the JRI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nuveen Real Assetome and Growth Fund Business Description

Address 333 West Wacker Drive, Chicago, IL, USA, 60606
Nuveen Real Asset Income and Growth Fund is a closed-end fund. Its objective is to provide a high level of current income and long-term capital appreciation. The fund invests a majority of its managed assets in equity and debt securities issued by real asset related companies located anywhere in the world. Its plan involves investments in five security types, infrastructure common stock, REIT preferred stock and debt securities. Real asset-related companies include those engaged in owning, operating, or developing infrastructure projects, facilities, and services, as well as REITs.
50GF Score

Get the complete analysis for JRI

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$12.94
Price
$23.36
GF Value